HEART TRANSPLANTATION - ADULT (HTX) -> HTX - Coronary Artery Vasculopathy Abstracts

596 - High Serum Phosphate is Associated with Increased Cardiac Allograft Vasculopathy and Adverse Cardiac Events Following Heart Transplantation

Presentation Number
596
Speakers
Session Name
POSTER SESSION 1 - POSTER SESSION: Heart Transplantation - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
587 - Dynamic Computed Tomography Perfusion for Diagnosis of Cellular Rejection after Heart Transplantation

Next ePresentations
597 - Regional Variability of Cardiac Allograft Vasculopathy by Intravascular Ultrasound Assessment
598 - Pre-Transplant Collagen Vascular Disease as a Risk Factor for Increase in Cardiac Allograft Vasculopathy after Heart Transplantation
602 - Global Coronary Artery Flow Reserve after Heart Transplantation: Recipient or Donor Age-Driven?
605 - Donor-Transmitted Atherosclerosis and the Occurrence of Cardiac Antibody-Mediated Rejection Influenced on the Development of Cardiac Allograft Vasculopathy
607 - Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study
612 - Comparing Mortality in Heart Transplantation Utilizing Donor Hearts with and without CAD
613 - Orthotopic Heart Transplantation in the Diabetic Patient, are We Still Worried? A Review of 952 Consecutive Patients
614 - Left Atrial Volume after Heart Transplantation - A Predictor of Outcomes?
615 - Blood Urea Nitrogen to Creatinine Ratio at Listing is Associated with Poor Outcomes in Heart Transplant Recipients with Stage 3 Chronic Kidney Disease
617 - The Combined Use of Gene Expression Profile and Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients: The Mid America Experience